The Medical Device Business Journal — Medical Device News & Articles | MassDevice
SynCardia said it brought in another $14 million funding round, led by a $10 million contribution from SWK Holdings, that it plans to use to develop a smaller version of its total artificial heart.
Tucson-based SynCardia said Athyrium Capital Management contributed the remaining $4 million as a follow-on to its $10 million investment in March.
Shadow Robot Co.’s so-called bionic man is making its way across the world, parading about a $1 million worth of advanced medical prosthetics that allow him to walk, breath and even hold light conversation.
The bionic man, the 1st of his kind, is a composite of parts from various medical device makers, including robotic feet and ankles from Massachusetts-based BiOM, an artificial heart made by Arizona’s SynCardia Systems and a retinal prosthesis from California’s Second Sight Medical.
Syncardia put together a $19 million financing package to back the spinout of its total artificial heart technology, hard on the heels of an FDA win for the device.
The bulk of the financing, $15 million, was doled out by New York-based funding group Athyrium Investors, with the balance coming from existing backers.
SynCardia Systems won 2 new Humanitarian Use Device designations for its 50cc Total Artificial Heart as a cardiac bridge transplant device.
The new HUD designations apply to use with children, smaller women and other people with small stature. The Tuscon, Ariz.-based device manufacturer designed this device as a smaller version of its 70cc temporary Total Artificial Heart, approved in 2004, according to a press release.
Allezoe Medical Holdings (OTC:ALZM) said board member and secretary Hyman White broke its internal rules and possibly state and federal laws when he wrote an affidavit supporting the un-named plaintiff in a lawsuit filed against Allezoe.
